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Russian Dandelion (Taraxacum kok-
saghyz) is an upcoming new crop. It is 
able to produce a cis-1,4-polyisoprene 
(natural rubber) which is equivalent to 
the material conventionally obtained 
from the rubber tree (Hevea 
brasiliensis). The focus of the BMBF 
funded “EVITA” project is to introduce a 
herbicide resistance into T. koksaghyz 
for better weed management during 
cultivation. 
Classical as well as new breeding tech-
nologies have been used in order to 
change the DNA sequence of the gene 
encoding for the acetohydroxyacid syn-
thase (AHAS). The AHAS enzyme pos-
sesses an essential function in amino 
acid synthesis and is therefore a target 
for weed control in crops. 
EMS mutagenesis of T. koksaghyz seeds 
did result in tolerant plants, though the 
plants did not carry tolerance conferring 
mutations in AHAS1. 
For direct mutation of specific target 
sites in AHAS1, different CRISPR/Cas9 
approaches have been set up. Agrobac-
terium tumefaciens mediated transfor-
mation of T. koksaghyz explants with 
plasmids encoding for the Cas9 enzyme
as well as the single guide RNA (sgRNA) 
have been performed, but did not result 
in plants with favored mutations, so far. 
An in vitro cleavage assay to test the 
cleavage capability by using the specific 
sgRNAs and Cas9 was successful by 
showing induction of double strand 
breaks in AHAS1. 
As Agrobacterium mediated transfor-
mations did not lead to transformants 
up to now, transfection of protoplasts 
was done. Regeneration of plants from 
protoplasts is difficult and was therefore 
not the primary goal of this approach. 
The objective is to proof the 
CRISPR/Cas9 system being able to work 
not only in vitro but also in vivo. 
Therefore, two days after transfection of 
protoplasts with purified Streptococcus 
pyogenes Cas9 and sgRNA, protoplasts 
have been harvested and genomic DNA 
was isolated. Out of the DNA, AHAS1 
was amplified, cleaved in vitro (cleavage 
assay) and sequenced subsequently. 
Sequencing results will show, if and to 
what extent the CRISPR/Cas9 system did 
perform in vivo in T. koksaghyz proto-
plasts. 
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